The cyclooxygenase-2 theory of atopy and asthma

Pediatric Asthma, Allergy and Immunology

Volumn 13, Issue 1, 1999, Pages 43-50

  Varner, Arthur E ^a  

^a Allergy Diagnostic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLOOXYGENASE 2; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; PROSTAGLANDIN E2;

ALLERGIC DISEASE; ARTICLE; ASTHMA; ATOPY; BRONCHUS HYPERREACTIVITY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; HELPER CELL; HISTAMINE RELEASE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTOPOIESIS; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; VIRUS INFECTION;

EID: 0032781817     PISSN: 08831874     EISSN: None     Source Type: Journal    
DOI: 10.1089/pai.1999.13.43     Document Type: Article

References (68)

1. Varner AE, Busse WW, Lemanske RF, Jr. Hypothesis: decreased use of pediatric aspirin has contributed to the increasing prevalence of childhood asthma. Ann Allergy Asthma Immunol 1998;81:347-351.
2. Szentivanyi A. The beta adrenergic theory of the atopic abnormality in bronchial asthma. J Allergy 1968;42:203-232.
3. Townley RG. Elevated cAMP-phosphodiesterase in atopic disease: cause or effect? J Lab Clin Med 1993;121:15-17.
4. Hendley JO. The host response, not the virus, causes the symptoms of the common cold [Editorial comment]. Clin Infect Dis 1998;26:847-848.
5. Barnes PJ, Karin M. Nuclear factor-κB - a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066-1071.
6. Proud D, Gwaltney JM Jr, Hendley JO, et al. Increased levels of interleukin-1 are detected in nasal secretions during experimental rhinovirus colds. J Infect Dis 1994;169:1007-1013.
7. Zhu Z, Tang W, Ray A, et al. Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor κB-dependent transcriptional activation. J Clin Invest 1996;97:421-430.
8. Subauste MC, Jacoby DB, Richards SM, et al. Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J Clin Invest 1995;96:549-557.
9. Gern JE, Dick EC, Lee WM, et al. Rhinovirus enters but does not replicate inside monocytes and airway macrophages. J Immunol 1996;156:621-627.
10. Grunberg K, Smits HH, Timmers MC, et al. Experimental rhinovirus 16 infection. Effects on cell differentials and soluble markers in sputum in asthmatic subjects. Am J Respir Crit Care Med 1997;156:609-616.
11. 2 Am Rev Respir Dis 1987;135:72-77.
12. Hilkens CMU, Snijders A, Snijdewint FGM, et al. Modulation of T-cell cytokine secretion by accessory cell-derived products. Eur Respir J 1996;9(Suppl. 22):90s-94s.
13. Fraenkel DJ, Bardin PG, Sanderson, et al. Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. Am J Respir Crit Care Med 1995;151:879-886.
14. Dworski R, Sheller JR. Differential sensitivites of human blood monocytes and alveolar macrophages to the inhibition of prostaglandin endoperoxide synthase-2 by interleukin-4. Prostaglandins 1997;53:237-251.
15. Yano T, Hopkins HA, Hempel SL, et al. Interleukin-4 inhibits lipopolysaccharide-induced expression of prostaglandin H synthase-2 in human alveolar macrophages. J Cell Physiol 1995;165:77-82.
16. Niiro H, Otsuka T, Izuhara K, et al. Regulation by interleukin-10 and interleukin-4 of cyclooxygenase-2 expression in human neutrophils. Blood 1997;5:1621-1628.
17. Gentile DA, Patel A, Ollia C, et al. Reduced IL-10 production in allergic rhinitis patients during experimental influenza A virus infection [Abstract]. Am J Respir Crit Care Med 1997;155(4):A63.
18. Johnston SL. Mechanisms of asthma exacerbation. Clin Exp Allergy 1998;(Suppl)5:181-186.
19. 2 promotes B lymphocyte Ig isotype switching to IgE. J Immunol 1995;154:162-170.
20. Reddel H, Ware S, Marks G, et al. Differences between asthma exacerbations and poor asthma control. Lancet 1999;353:364-369.
21. Busse WW. Decreased granulocyte response to isoproterenol in asthma during upper respiratory infections. Am Rev Respir Dis 1977;115:783-791.
22. Buckner CK, Clayton DE, Ain-Shoka AA, et al. Parainfluenza 3 infection blocks the ability of a beta adrenergic receptor agonist to inhibit antigen-induced contraction of guinea pig isolated airway smooth muscle. J Clin Invest 1981;67:376-384.
23. Naclerio RM, Proud D, Lichtenstein LM, et al. Kinins are generated during experimental rhinovirus colds. J Infect Dis 1988;157:133-142.
24. Laporte JD, Moore PE, Panettieri RA et al. Prostanoids mediate IL-1 beta-induced beta-adrenergic hyporespon-siveness in human airway smooth muscle cells. Am J Physiol 1998;275(3 Pt 1):L491-501.
25. Pang L, Holland E, Knox AJ. Impaired cAMP production in human airway smooth muscle cells by bradykinin: role of cyclooxygenase products. Am J Physiol 1998; 2(Pt 1):L322-329.
26. Scarpace PJ, Bender BS. Viral pneumonia attenuates adenylate cyclase but not beta-adrenergic receptors in murine lung. Am Rev Respir Dis 1989;140:1602-1606.
27. Walters EH. Effect of inhibition of prostaglandin synthesis on induced bronchial hyperresponsiveness. Thorax 1983;38:195-199.
28. Sperber SJ, Hendley JO, Hayden FG, et al. Effects on naproxen on experimental rhinovirus colds. A randomized, double-blind, controlled trial. Ann Intern Med 1992;117:37-41.
29. Lesko SM, Mitchell AA. An assessment of the safety of pediatric ibuprofen. A practioner-based randomized clinical trial. JAMA 1995;273:929-933.
30. Lesko SM, Mitchell AA. Asthma morbidity following short-term use of acetaminophen and ibuprofen in asthmatic children [Abstract]. Pharmacoepidem Drug Safety 1995;4(Suppl 1):s43.
31. McAdam BF, Catella-lawson, Mardini IA, et al. Systemic biosynthesis of prostacyclin by cyclooxygenase-2 (COX-2): the human pharmacology of a selective inhibitor of COX-2. Proc Natl Acad Sci USA 1999;96:272-277.
32. de Gouw HWFM, Grunberg K, Schot R, et al. Relationship between exhaled nitric oxide and airway hyperresponsiveness following experimental rhinovirus infection in asthmatic subjects. Eur Respir J 1998;11: 126-132.
33. Berkman N, Robichaud A, Robbins RA, et al. Inhibition of inducible nitric oxide synthesis by interleukin-4 and interleukin-13 in human lung epithelial cells. Immunology 1996;89:363-367.
34. 2 and other cyclic AMP stimulants in J774 macrophages. Biochem Pharmacol 1997;53:493-500.
35. Brusasco V, Crimi E, Pellegrino R. Airway hyperresponsiveness in asthma: not just a matter of airway inflammation. Thorax 1998;53:992-998.
36. 2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993;150:353-360.
37. Takanaski S, Nonaka R, Xing Z, et al. Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils. J Exp Med 1994;180:711-715.
38. Borish L, Aarons A, Rumbyrt J, et al. Interleukin-10 regulation in normal subjects and patients with asthma. J Allergy Clin Immunol 1996;97:1288-1292.
39. Roberts CR. Is asthma a fibrotic disease? Chest 1995;107(Suppl 3):111s-117s.
40. Kovacs EJ, Dipietro LA. Fibrogenic cytokines and connective tissue production. FASEB J 1994;8:854-861.
41. Kirby JG, Hargreave FE, Cockroft DW, et al. Effect of indomcthacin on allergen-induced asthmatic response. J Appl Physiol 1989;66:578-583.
42. Bachelet M, Vincent D, Havet N, et al. Reduced responsiveness of adenylate cyclase in alveolar macrophages from patients with asthma. J Allergy Clin Immunol 1991;88:322-328.
43. Grewe SR, Chan SC, Hanifin JM. Elevated leukocyte cyclic-AMP phosphodiesterase in atopic disease: a possible mechanism for cyclic AMP-agonist hyporesponsiveness. J Allergy Clin Immunol 1982;70:452-457.
44. Butler JM, Chan SC, Stevens S, et al. Increased leukocyte histamine release with elevated cyclic AMP-phosphodiesterase activity in atopic dermatitis. J Allergy Clin Immunol 1983;71:490-497.
45. Safko MJ, Chan SC, Cooper KD, et al. Heterologous desensitization of leukocytes: a possible mechanism for beta adrenergic blockade in atopic dermatitis. J Allergy Clin Immunol 1981;68:218-225.
46. Rothenberg ME. Eosinophilia. N Engl J Med 1998;338:1592-1600.
47. Martinez FD, Stern DAA, Wright AL, at al. Differential immune responses to acute lower respiratory illness in early life and subsequent development of wheezing and asthma. J Allergy Clin Immunol 1998;102:915-920.
48. Roman M, Calhoun WJ, Hinton KL, et al. Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response. Am J Respir Crit Care Med 1997;156:190-195.
49. Kawamori T, Rao CV, Seibert K, et al. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon cancer. Cancer Res 1998;58:409-412.
50. Herschman HR. Prostaglandin synthase 2. Biochimica Biophysica Acta 1996:1299:125-140.
51. 2 by microfilariae of Wuchereria bancrofti and Brugia malayi. Am J Trop Med Hyg 1992;46:520-523.
52. 2 regulation of cytokine production in atopic dermatitis. J Immunol 1993;151:3345-3352.
53. 2 production by monocytes in atopic dermatitis (AD) is not accompanied by enhanced production of IL-6, IL-10, and IL-12. Clin Exp Immunol 1998;111:472-476.
54. Hart LA, Krishnan VL, Adcock IM, et al. Activation and localization of transcription factor, nuclear factor-κB, in asthma. Am J Respir Crit Care Med 1998;158:1585-1592.
55. Adcock IM, Shirasaki H, Gelder CM, et al. The effects of glucocorticoids on phorbol ester and cytokine stimulated transcription factor activation in human lung. Life Sci 1994;55:1147-1153.
56. Dworski RT, Funk CD, Dates JA, et al. Prednisone increases PGH-synthase 2 in atopic humans in vivo. Am J Respir Crit Care Med 1997;155:351-357.
57. Robinson D, Hamid Q, Ying S, et al. Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-gamma cytokine gene expression. Am Rev Respir Dis 1993;148:401-406.
58. Jenkins CR, Woolcock AJ. Effect of prednisone and beclomethasone diproprionate on airway responsiveness in asthma: a comparative study. Torax 1988;43:378-384.
59. Demoly P, Crampette L, Lebel B, et al. Expression of cyclo-oxygenase 1 and 2 proteins in upper respiratory mucosa. Clin Exp Allergy 1998;28:278-283.
60. 2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;324:1110-1118.
61. Gauvreau GM, Jordana M, Watson RM, et al. Effect of regular inhaled albuterol on allergen-induced late responses and sputum eosinophilia in asthmatic subjects. Am J Respir Crit Care Med 1997;156:1738-1745.
62. Fedyk ER, Adawi A, Looney J, et al. Regulation of IgE and cytokine production by cAMP: implications for extrinsic asthma. Clin Immunol Immunopathol 1996;81:101-113.
63. 1 development by selective inhibition of interleukin 12. J Clin Invest 1997;100:1513-1519.
64. Cummings NP, Morris HG, Strunk RC. Failure of children with asthma to respond to daily aspirin therapy. J Allergy Clin Immunol 1983;71:245-249.
65. Speir E., Yu ZX, Ferrans VJ, Huang ES, Epstein SE. Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells. Circ Res 1998;83:210-216.
66. Stewart WF, Kawas C, Corrada M, Metter EJ. Risk of alzheimer's disease and duration of NSAID use. Neurology 1997;48:626-632.
67. Gordon MC, Samuels P, Indomethacin. Clin. Obstetr. Gyn. 1995;38:697-705.
68. Bone RC. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction syndrome (MDOS). Ann. Intern. Med. 1996; 125:680-687.